This week, James is joined by Dr. Meriem Sefta, PhD, Chief Diagnostics Officer at Owkin. Owkin is the first end-to-end AI-biotech company on a mission to understand complex biology and ensure every patient gets the right treatment using AI trained on world-class patient data through privacy-enhancing technologies.

Learn more: https://www.owkin.com/diagnostics-approach

Apply to be a guest: www.thehealthtechpodcast.com

Subscribe to Healthtech Pigeon 🐦:
www.healthtechpigeon.com

Get in touch with James: www.jamessomauroo.com

Learn more about SomX for your healthtech company at somx.health

#373 Digitising Pathology: Why AI is the Future of Cancer Treatment with Meriem Sefta from Owkin